Fulcrum Therapeutics, Inc. (FULC) Social Stream
Fulcrum Therapeutics Inc (FULC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering FULC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-10 | 6 | $46 | $16 | $36.333 | $24 | 51.39% |
| 2022-02-01 | 6 | $46 | $16 | $34.833 | $24 | 45.14% |
| 2022-03-04 | 6 | $46 | $16 | $34.833 | $24 | 45.14% |
| 2022-03-07 | 6 | $43 | $16 | $33.833 | $24 | 40.97% |
| 2022-03-08 | 7 | $43 | $16 | $33.714 | $24 | 40.47% |
| 2022-03-30 | 7 | $43 | $18 | $34 | $24 | 41.67% |
The Trend in the Analyst Price Target
Over the past 43 weeks, FULC's average price target has gone up $14.87.
Over the past 51 weeks, FULC's average upside potential has been 96.77%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-26 | 4 | 39 | 11 | 20.880 | 9.00 | 132% |
| 2021-08-01 | 4 | 39 | 11 | 20.880 | 7.31 | 185.64% |
| 2021-09-04 | 7 | 46 | 12 | 34.860 | 28.07 | 24.19% |
| 2021-11-19 | 6 | 46 | 16 | 36.333 | 17.14 | 111.98% |
| 2022-03-07 | 7 | 43 | 16 | 33.833 | 14.90 | 127.07% |
FULC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.36 | 5 | 1 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 30 weeks, FULC's average broker recommendation rating improved by 0.71.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, Fulcrum Therapeutics Inc's variance in analysts' estimates is lower than -418.36% of them.
- Fulcrum Therapeutics Inc's number of analysts covering the stock is higher than 492.81% of stocks in the small market cap category.
- FULC has a higher upside potential (average analyst target price relative to current price) than 123.34% of Pharmaceutical Products stocks.
- FULC has a greater average analyst price target than 449.04% of stocks in the small market cap category.
Stocks similar to Fulcrum Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FREQ, FIXX, and FHTX.
Is FULC a Buy, Hold or Sell? See the POWR Ratings now!